Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil vs Esmolol for Controlled Hypotension in FESS
NCT02967029Phase 4Completed
- Sponsor
- Istanbul University
- Start
- Nov 2016
- Primary completion
- Jul 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of remifentanil in chronic rhinosinusitis (CRS), sponsored by Istanbul University. Started Nov 2016; status: completed.
02
Drugs
remifentanil
03
Conditions
chronic rhinosinusitis (CRS)
Beyond the preview
Go deeper on NCT02967029.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02967029.